Triamcinolone and Enterovesical fistula - a phase IV clinical study of FDA data

Summary:

Enterovesical fistula is reported as a side effect among people who take Triamcinolone (triamcinolone), especially for people who are female, 60+ old, also take Nifedipine, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Enterovesical fistula when taking Triamcinolone. It is created by eHealthMe based on reports of 25,490 people who have side effects when taking Triamcinolone from the FDA, and is updated regularly.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

What is Enterovesical fistula?

Enterovesical fistula is found to be associated with 152 drugs and 264 conditions by eHealthMe. Check the latest studies of Enterovesical fistula.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

25,490 people reported to have side effects when taking Triamcinolone.
Among them, 13 people (0.05%) have Enterovesical fistula.

Could Triamcinolone cause Enterovesical fistula?

Among these 13 people:

What is the gender of people who have Enterovesical fistula when taking Triamcinolone? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Enterovesical fistula when taking Triamcinolone? *

What are other drugs people take besides Triamcinolone? *

Nifedipine: 12 people, 92.31%
Oxybutynin: 11 people, 84.62%
Aspirin: 11 people, 84.62%
Paxil: 11 people, 84.62%
Nystatin: 11 people, 84.62%
Nisoldipine: 11 people, 84.62%
Chlorhexidine Gluconate: 11 people, 84.62%
Ms Contin: 11 people, 84.62%
Morphine Sulfate: 11 people, 84.62%
Metronidazole: 11 people, 84.62%

What are other side effects people have besides Enterovesical fistula? *

Urinary Tract Infection: 12 people, 92.31%
Weight Loss: 11 people, 84.62%
Hypophagia (reduced food intake): 11 people, 84.62%
Orthopnea (shortness of breath (dyspnea) when lying down): 11 people, 84.62%
Oropharyngeal Pain: 11 people, 84.62%
Oedema Peripheral (superficial swelling): 11 people, 84.62%
Cataract (clouding of the lens inside the eye): 11 people, 84.62%
Multiple Myeloma (cancer of the plasma cells): 11 people, 84.62%
Mouth Ulcers: 11 people, 84.62%
Chills (felling of cold): 11 people, 84.62%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 84.62%
High Blood Pressure: 2 people, 15.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
Benign Neoplasm Of Prostate (benign (non-cancerous) tumours of the prostate): 1 person, 7.69%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 1 person, 7.69%
Constipation: 1 person, 7.69%
Depression: 1 person, 7.69%
Gastric Mucosal Hypertrophy (inflammation and ulcers (breaks on the skin or on the surface of an organ) of the mucosa (inner lining) of the stomach): 1 person, 7.69%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 1 person, 7.69%
Sleep Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and have Enterovesical fistula?

- Check whether Enterovesical fistula is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triamcinolone:

Triamcinolone (25,577 reports)

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterovesical fistula:

Enterovesical fistula (152 drugs)

Browse all the conditions that are associated with Enterovesical fistula:

Enterovesical fistula (264 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone (the active ingredients of Triamcinolone) and Triamcinolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.